One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study.

Jasbir DhaliwalHayley E McKayColette DeslandresJennifer DebruynEytan WineAshley WuHien HuynhNicholas CarmanEileen CrowleyPeter C ChurchThomas D WaltersAmanda Ricciuto Anne M Griffithsnull null

Published in: Alimentary pharmacology & therapeutics (2021)

Ustekinumab demonstrated efficacy in this paediatric cohort with otherwise treatment-refractory UC. Treatment failure was not due to inadequate drug exposure.

Keyphrases

ulcerative colitis
intensive care unit
clinical trial
stem cells
randomized controlled trial
mesenchymal stem cells
adverse drug
weight loss
smoking cessation